Bank of America Downgrades Marvell on Lumentum Deal
The bank cut its rating and price target on Marvell as the chipmaker pursues a more than $100 billion all-stock purchase of Lumentum.
Updated on Nov. 3, 2026 in Business Strategy
Bank of America downgraded Marvell Technology to neutral from buy and lowered its price target to $225 from $400. Marvell shares fell 13% on November 2 after the company announced an all-stock purchase of Lumentum valued at more than $100 billion.
Why it matters
The downgrade reflects concern that the planned acquisition could dilute existing shareholders and face an extended regulatory review, including in China. Marvell has described the deal as a move to build a leading position in AI connectivity.
Bank of America's new $225 target sits 31% above Marvell's November 2 close, down from $400, while the all-stock Lumentum deal would dilute Marvell's share count by about 50%. The bank expects $1 billion in cost cuts but says those savings would not offset the dilution, and the deal's regulatory timeline remains unresolved.
The players
Bank of America
Bank of America is one of the largest U.S. banking and financial services companies, with a major equity research division that issues ratings on public companies.
Marvell Technology
Marvell Technology is a U.S.-based semiconductor company that designs chips for data center, networking, and AI infrastructure markets.
Lumentum
Lumentum is a U.S.-based optical and photonics company that makes components used in high-speed networking and data communications.
The details
Bank of America cited risks tied to Marvell's planned Lumentum acquisition, including the possibility of an extended regulatory review in China. The bank said expected cost cuts of $1 billion would not be enough to offset the dilution from issuing new shares.
Timeline
November 2, 2026: Marvell shares fell 13% after the Lumentum acquisition was announced.
November 3, 2026: Bank of America downgraded Marvell to neutral and cut its price target to $225.
Market Landscape
Large all-stock chip deals have repeatedly forced analysts to weigh share dilution against strategic gains in AI connectivity. Marvell's planned purchase of Lumentum places it in that same competitive push to secure optical and networking capacity for AI data centers.
For investors holding Marvell, the downgrade and the roughly 50% dilution from the all-stock deal could affect the value of existing shares. Shareholders should watch for updates on the pending Lumentum regulatory review, including in China, before the deal closes.
The takeaway
Large all-stock acquisitions can dilute existing shareholders even when they promise cost savings and strategic gains. Investors should compare projected synergies against the share count increase before judging a deal.
Further reading
Explore more coverage in Business Strategy to see how companies weigh large acquisitions against shareholder dilution.
Source note: This article includes information reported by TokenPost.
